India won’t buy Pfizer, Moderna Covid doses amid jump in local output: Report
Live MintNew Delhi: India's government will not buy COVID-19 shots from Pfizer/BioNTech and Moderna, three government sources told Reuters, mainly because domestic output of more affordable and easier-to-store vaccines has jumped. "Earlier, there was a shortage, there was a need," said one of the sources, referring to India's appeal to the companies in April for vaccines when infections exploded and shots were in short supply. Moderna, through its Indian partner Cipla, already has emergency-use authorisation in India for its vaccine, which, like the Pfizer one, needs ultra-cold storage - facilities that much of India lacks. India's monthly domestic output has trebled since April and will reach 300 million doses in October, according to Health Minister Mansukh Mandaviya, who on Monday announced a restart of India's vaccine exports from the October quarter.